Detalhe da pesquisa
1.
Demographically adjusted Rey-Osterrieth Complex Figure Test norms in a Swedish and Norwegian cohort aged 49-77 years and comparison with North American norms.
Scand J Psychol
; 65(2): 168-178, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37721999
2.
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease.
J Neuroinflammation
; 20(1): 298, 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38093257
3.
A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia.
Am J Geriatr Psychiatry
; 31(2): 141-151, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372613
4.
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
Acta Neuropathol
; 144(5): 821-842, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066633
5.
Timed Up and Go in People with Subjective Cognitive Decline Is Associated with Faster Cognitive Deterioration and Cortical Thickness.
Dement Geriatr Cogn Disord
; 51(1): 63-72, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339996
6.
The Relationship of Psychiatric Symptoms with Performance-Based and Self-Reported Cognitive Function After Ischemic Stroke.
J Int Neuropsychol Soc
; 28(1): 35-47, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785079
7.
Characteristics of subjective cognitive decline associated with amyloid positivity.
Alzheimers Dement
; 18(10): 1832-1845, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877782
8.
Next-Generation RNA-Sequencing of Serum Small Extracellular Vesicles Discovers Potential Diagnostic Biomarkers for Dementia With Lewy Bodies.
Am J Geriatr Psychiatry
; 29(6): 573-584, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160816
9.
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Int Psychogeriatr
; 33(11): 1217-1228, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34399870
10.
Glial activation and inflammation along the Alzheimer's disease continuum.
J Neuroinflammation
; 16(1): 46, 2019 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30791945
11.
Convergent Results from Neuropsychology and from Neuroimaging in Patients with Mild Cognitive Impairment.
Dement Geriatr Cogn Disord
; 43(3-4): 144-154, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28152536
12.
Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.
Circulation
; 131(23): 2061-2069, 2015 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25862742
13.
Isobaric Quantification of Cerebrospinal Fluid Amyloid-ß Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
J Proteome Res
; 14(11): 4834-43, 2015 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26452689
14.
Hippocampal Subfield Atrophy in Multi-Domain but Not Amnestic Mild Cognitive Impairment.
Dement Geriatr Cogn Disord
; 40(1-2): 44-53, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25924735
15.
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
JAMA
; 313(19): 1924-38, 2015 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25988462
16.
Cerebrospinal fluid neurofilament light chain mediates age-associated lower learning and memory in healthy adults.
Neurobiol Aging
; 135: 39-47, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159464
17.
Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohorts.
Front Aging Neurosci
; 16: 1345417, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469163
18.
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease.
Nat Commun
; 15(1): 2908, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575616
19.
Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia: Recent Progress on the Mechanisms and Interventional Strategies.
J Gerontol A Biol Sci Med Sci
; 79(4)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289789
20.
Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer's disease (DEBBIE-AD): a prospective observational multicohort study protocol.
BMJ Open
; 14(3): e081635, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458785